Ionis Pharma (IONS) Announces Licensing of IONIS-JBI1-2.5Rx to Janssen

July 19, 2016 7:03 AM

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced that it has earned $10 million from Janssen Biotech, Inc. (Janssen) upon licensing IONIS-JBI1-2.5Rx ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found